Ziel Launches New Microbial Control Solution for Cannabis

The industry solutions provider introduced the RFX, its newest generation of radio frequency technology to control microbial pathogens in cannabis while retaining product sensory qualities.

© Ziel | ziel.com
Ziel RFX

SAN FRANCISCO, Nov. 15, 2023 – PRESS RELEASE – Ziel introduced its next generation, microbial control solution to the cannabis market, the Ziel RFX. The RFX has a greater than 99% pass rate and the highest volume throughput in the industry with the capacity to process 160 pounds of cannabis in an eight-hour shift. Additionally, Ziel’s radio frequency technology is suitable for use in organic cannabis cultivation operations and preserves the enzymatic properties that make each cannabis strain unique.

“The Ziel RFX is the result of seven years’ operational experience successfully processing hundreds of tons of flower using radio frequency technology,” Ziel CEO and co-founder Arthur de Cordova said. “This expertise has been harnessed to create a sleek, compact design that runs on single phase power and delivers the highest throughput in the industry. All at the lowest processing cost per pound.”

Three years in the making, the Ziel RFX is a collaboration between Ziel and STALAM, the world’s largest manufacturer of radio frequency equipment with installations in more than 70 countries. The exterior and user interface was designed by Ammunition Group, a global industrial design firm led by Richard Brunner, who was previously director of industrial design at Apple and launched that company’s design practice 30 years ago.

The propriety process solutions offered by Ziel are the first ever patented for use in the treatment of cannabis using radio frequency technology for microbial reduction. Radio frequency is a thermal process that reverses the polarity of naturally occurring water molecules in agricultural products, including cannabis flower. Water molecules oscillate 27 million times per second, generating consistent even volumetric heat that kills pathogens based on Ziel’s proprietary processing parameters.

To learn more about Ziel or the RFX, please visit www.ziel.com.